NHF’s ACT campaign, “Access to Care Today, Achieve a Cure Tomorrow,” is in full swing. The five year, multi-million dollar fundraising campaign sets its sights on several goals. Donations will help strengthen NHF’s network of chapters, ensuring that patients in every state have access to the full range of treatment products, high-quality hemophilia treatment centers (HTCs), high standards of care and adequate reimbursement for life-saving therapies. Affinity groups participating in the campaign include NHF chapters, the Board of Directors, MASAC, HTCs, corporations and individuals.
Learn more about the Campaign for Our Future or please make a donation now.
The Visionary Corporate Partner and Lead Benefactor for the campaign is Novo Nordisk. Other sponsors are: Baxter, Principal Corporate Partner; Bayer, CSL Behring, and Wyeth, Major Corporate Partners; and Grifols, Corporate Partner.